This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
IRVINE, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX:TRTC), (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, is pleased to announce it has agreed to sell 100% of the assets of its cannabis dispensary located at 1921 Western Avenue in Las Vegas, to Exhale Brands Nevada, for a total consideration of $6,250,000.
The company paid $51.5m for a dispensary in a related party transaction, 1st dispensary license was received via bribery.
MS.PRI TRTC MS.PRK GTHP MS.PRE MS.PRF MS.PRG MS NRTI MS.PRA
(Reuters) - The company that owns High Times, a magazine devoted to marijuana culture, announced on Tuesday that it is launching an equity crowdfunding campaign ahead of its application for an initial public offering on Nasdaq later this year.
TWMJF TRTC WEED DTK MSRT CGC
trtc_10ka.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Chicago, IL – June 8, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Innovative Industrial Properties, Inc. (IIPR - Free Report) and GW Pharmaceuticals PLC (GWPH - Free Report) .
GRWG TTWO FIX LB IIPR.PRA IIPR GWPH BKNG UFPI APH TRTC MU PATK PETS APHQF GWP
IRVINE, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX:TRTC), a vertically integrated cannabis-focused agriculture company, is pleased to announce that it has commenced cultivation at its new Sparks facility, following approval from the State of Nevada. Utilizing Terra Tech’s proven practices and procedures, the team has successfully begun cultivation of its first cannabis crop, planting the first seeds in early June.
When it comes to cannabis, we’ve come a long way since former President Bill Clinton denied ever inhaling. With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible.
IGCIW MNTR IGC ACBFF DTK HEMP TRTCD CANN LXX CVSI CBIS SRNA LDSYF MJNA APH AMMJ ACAN ABBV SMG LXRP INQD MDCL MSC.H CARA RMHB IIPR.PRA POTN ACB IIPR IMLFF KAYS PKPH TRTC GRNH ABBV APHQF
2017-11-16 - Asif
Terra Tech is a holding company with the following subsidiaries: Edible Garden Corp., a Nevada corporation (“Edible Garden”); MediFarm, LLC, a Nevada limited liability company (“MediFarm”); MediFarm I, LLC, a Nevada limited liability company (“MediFarm I”); MediFarm I Real Estate, LLC, a Nevada limited liability company (“MediFarm I RE”); MediFarm II, LLC, a Nevada limited liability company (“MediFarm II”); IVXX, LLC, a Nevada limited liability company (“IVXX LLC”); IVXX, Inc., a California corporation (“IVXX Inc.”; together with IVXX LLC, “IVXX”); Blüm San Leandro, a California corporation (“Blüm San Leandro”); Black Oak Gallery, a California corporation (“Black Oak”); GrowOp Technology Ltd., a Nevada corporation (“GrowOp Technology”); EG Transportation, LLC, a Nevada limited liability company (“EG Transportation”); and MediFarm So Cal, Inc., a California mutual benefit corporation (“MediFarm SoCal”) History and Background On Febru...
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to TRTC / Terra Tech Corp. on message board site Silicon Investor.
|TRTC - All the Characteristics of a Winner|
as of ET